Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06035692
Other study ID # BPB
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2023
Est. completion date June 30, 2024

Study information

Verified date February 2024
Source The First Affiliated Hospital with Nanjing Medical University
Contact Feng Feng, M.D
Phone 13814073686
Email 316637881@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was toinvestigate the effect of BPB on outcome of upper extremity arteries in patients undergoing interventional embolization of intracranial aneurysms via TRA. A multicenter prospective clinical trial was designed. The study subjects were patients undergoing cerebral aneurysm embolization with TRA. BPB was given in the BPB group patients and no BPB in the control group.The incidence of radial artery spasm (RAS) diagnosed by intraoperative angiography and the occurrence of the unfavorable RA for repeated trans-radial interventions (TRI) diagnosed by vascular ultrasound 1 month after surgery, perioperative changes of blood flow parameters in upper limb vessels,postoperative inflammatory factors and complications were observed in the two groups.


Description:

The aim of this study was to investigate the effect of BPB on outcome of upper extremity arteries in patients undergoing interventional embolization of intracranial aneurysms via TRA. A multicenter prospective clinical trial was designed, and the study subjects were patients undergoing cerebral aneurysm embolization with TRA. Participants were randomly assigned to receive Ultrasound-guided BPB with 0.15% ropivacaine 20ml (BPB group) or normal saline 20ml (Control group) in 1:1ratio.The primary outcomes measured were the incidence of RAS diagnosed by intraoperative angiography and the occurrence of the unfavorable RA for repeated trans-radial interventions (TRI) diagnosed by vascular ultrasound 1 month after surgery.Secondary outcomes included the severity of RAS, Components of unfavorable RA for repeated TRI, intraoperative nitroglycerin use, Intraoperative hypotension, surgeon satisfaction scores.


Recruitment information / eligibility

Status Recruiting
Enrollment 176
Est. completion date June 30, 2024
Est. primary completion date February 29, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - 18-75 years old, BMI<28kg/m2 - ASA physical status ?-? - Elective interventional surgery for intracranial aneurysms via TRA - willing to sign informed consent Exclusion Criteria: - patients allergic to local anesthetics - neck infection on the surgical side - Preoperative upper extremity ultrasound or DSA showed radial artery occlusion and arteriovenous fistula - The diameter of radial artery was still less than 2mm after brachial plexus block - Axillary artery occlusion and other vascular anatomical abnormalities may affect the operation - Radial artery patency: Barbeau type D - The history of hand trauma may affect the establishment of radial artery; access, or the use of radial artery as a bypass or dialysis vessel - patients with incomplete block effect after nerve block were detected; - The patient refused to participate in the study or cooperate with the follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ropivacaine
According to the results of the preliminary experiment, the BPB group was given ultrasound-guided BPB with 0.15% ropivacaine 20ml.The ropivacaine concentration was the 90% minimum effective concentration(MEC90) for preventing vasospasm during operation.

Locations

Country Name City State
China The First Affiliated Hospital with Nanjing Medical University Nanjing Jiangsu

Sponsors (4)

Lead Sponsor Collaborator
The First Affiliated Hospital with Nanjing Medical University Huizhou Municipal Central Hospital, Nanjing Jiangbei Hospital, Xuzhou Central Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Calculate MEC50 and MEC95 of ropivacaine in brachial plexus block by sequential method The minimum effective concentration(MEC50 and MEC90) of ropivacaine for brachial plexus block to prevent radial artery spasm during operation was determined by sequential method. During the operation
Other Record diameter and the hemodynamic parameters of radial artery by ultrasound The radial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. Day 1 before surgery
Other Record diameter and the hemodynamic parameters of brachial artery by ultrasound The brachial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. Day 1 before surgery
Other Record diameter and the hemodynamic parameters of ulnar artery by ultrasound The ulnar artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. Day 1 before surgery
Primary Assess the RAS by angiography at the begining of the operation The RAS was assessed through radial artery angiography following the insertion of the arterial catheter. During the operation
Primary Evaluate the degree of RAS by angiography at the end of the operation The severity of RAS was classified as severe, moderate, or mild based on the degree of stenosis observed on radial arteriography: greater than 75%, 25-75%, and less than 25% of the vessel diameter, respectively. In addition, if the combined spasm length exceeded 2cm, the severity increased by 1 grade. During the operation
Secondary Assess unfavorable RA for repeated trans-radial interventions (TRI) at 1 month after surgery by ultrasonography. The the radial artery was evaluated at 1 month after surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments.The radial artery was considered unfavorable for repeated-TRI if it exhibited any of the following criteria: total occlusion, intima-media thickness (IMT) =0.5 mm and diameter <1.5mm, moderate and diffuse stenosis (> 10 mm in length), or severe focal or diffuse stenosis (regardless of length). Month 1 after surgery
Secondary Record the incidence of intima-media thickness (IMT) =0.5 mm and diameter <1.5mm at 1 month after surgery by ultrasonography. The incidence of intima-media thickness (IMT) =0.5 mm and diameter <1.5mm as a component of unfavorable RA for repeated TRI was recorded at one month follow-up. Month 1 after surgery
Secondary Record the incidence of radial artery occlusion at 1 month after surgery by ultrasonography. The incidence of radial artery occlusion as a component of unfavorable RA for repeated TRI was recorded at one month follow-up. Month 1 after surgery
Secondary Record the incidence of moderate and diffuse stenosis (> 10 mm in length) at 1 month after surgery by ultrasonography. The incidence of moderate and diffuse stenosis (> 10 mm in length) as a component of unfavorable RA for repeated TRI was recorded at one month follow-up. Month 1 after surgery
Secondary Record the incidence of severe focal or diffuse stenosis (regardless of length) at 1 month after surgery by ultrasonography. The incidence of severe focal or diffuse stenosis (regardless of length) as a component of unfavorable RA for repeated TRI was recorded at one month follow-up. Month 1 after surgery
Secondary Record the use of nitroglycerin during the operation When the radial sheath was inserted, upper limb angiography was performed, and nitroglycerin 200ug was administered if any degree of vasospasm in the upper limb was observed on the angiography. The administration of nitroglycerin in each group was recorded. During the operation
Secondary Record the incidence of intraoperative hypotension The definition of intraoperative hypotension was a mean arterial blood pressure below 60mmHg. During the operation
Secondary Record physician satisfaction by questionnaire Physician satisfaction was scored on a scale of 1-10, with a score of 1 indicating very poor and dissatisfied experience and a score of 10 indicating very satisfied. The surgeons were asked to fill in the satisfaction questionnaire according to the operation situation after operation and recorded. Day 0 after the surgery
Secondary Record the duration of radial artery puncture The time from the beginning of the radial artery puncture to the placement of the radial sheath was recorded. At the begining of the operation
Secondary Measured diameter and the hemodynamic parameters of radial artery by ultrasound 30min after BPB or control interventions The radial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. 30min after BPB or control interventions
Secondary Measured diameter and the hemodynamic parameters of radial artery by ultrasound 24h after surgery The radial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. 24h after surgery
Secondary Measured diameter and the hemodynamic parameters of radial artery by ultrasound 1 month after surgery The radial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. Month 1 after surgery
Secondary Measured diameter and the hemodynamic parameters of ulnar artery by ultrasound 30min after BPB or control interventions The ulnar artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. 30min after BPB or control interventions
Secondary Measured diameter and the hemodynamic parameters of ulnar artery by ultrasound 24h after surgery The ulnar artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. 24h after surgery
Secondary Measured diameter and the hemodynamic parameters of ulnar artery by ultrasound 1 month after surgery The ulnar artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. Month 1 after surgery
Secondary Measured diameter and the hemodynamic parameters of brachial artery by ultrasound 30min after BPB or control interventions The brachial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. 30min after BPB or control interventions
Secondary Measured diameter and the hemodynamic parameters of brachial artery by ultrasound 24h after surgery The brachial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. 24h after surgery
Secondary Measured diameter and the hemodynamic parameters of brachial artery by ultrasound 1 month after surgery The brachial artery was evaluated(include diameter, PSV,EDV,TAMAX,PI,RI) before the surgery using ultrasonography by an anesthesiologist who was blinded to the group assignments. Month 1 after surgery
Secondary Record mean arterial pressure at different time points The mean intraoperative arterial pressure from T0 to T8 was recorded. T0 indicates time after entering the operating room; T1,30 minutes after BPB or control procedure; T2, 5 minutes after induction of general anesthesia; T3, angiography after the radial sheath enters the radial artery; T4,1minutes after angiography; T5, 3minutes after angiography; T6, 5minutes after angiography; T7, 10 minutes after angiography; T8, completion of the operation. During the operation
Secondary Record perioperative complications Perioperative complications include puncture site complications, brachial plexus complications, and other cardiovascular and cerebrovascular complications Day 1 after the surgery
Secondary Recorded the levels of eight inflammatory factors The hospital laboratory conducted an examination on 8 inflammatory factors (include IL-2,IL-4,IL-6,IL-10,IL-17,IL-12P70,IFN-r,TNF-a) to assess postoperative infection, and subsequently provided the results. Day 1 after the surgery
Secondary Recorded the incidence of postoperative acute embolism events A head magnetic resonance imaging(MRI) was conducted to document the occurrence of postoperative embolic events, such as acute cerebral infarction. Day 1 after the surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04870047 - Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation N/A
Recruiting NCT05968053 - Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Not yet recruiting NCT05665309 - Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor N/A
Completed NCT02783339 - Neuroform Atlas Stent for Intracranial Aneurysm Treatment
Withdrawn NCT01194388 - Axium Coil in Completing Endovascular Aneurysm Surgery Study
Completed NCT00071565 - Familial Intracranial Aneurysm Study II N/A
Recruiting NCT05409989 - MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study N/A
Completed NCT03680742 - Contour Neurovascular System - European Pre-Market Unruptured Aneurysm N/A
Completed NCT04872842 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
Terminated NCT02532517 - Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device N/A
Completed NCT03663257 - Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
Recruiting NCT06189950 - Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE N/A
Recruiting NCT05608122 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on Regional Medical Centers in China and Population Follow-up Study (Phase Ⅱ)
Recruiting NCT03661463 - Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). Phase 2
Completed NCT02609867 - A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise) N/A
Active, not recruiting NCT02292017 - Prospective Packing Density With Target Coils I N/A
Active, not recruiting NCT01872741 - Minipterional Versus Pterional Craniotomy N/A
Completed NCT00993057 - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia Early Phase 1
Completed NCT00777088 - Pipeline for Uncoilable or Failed Aneurysms N/A
Completed NCT00777907 - Complete Occlusion of Coilable Aneurysms Phase 3